{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:08:26Z","timestamp":1790798906709,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gim.2025.101505","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:25:22Z","timestamp":1754479522000},"page":"101505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"27","author":[{"given":"Glenn E.","family":"Palomaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Rowsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.E.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn","family":"Messerlian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9360","key":"10.1016\/j.gim.2025.101505_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(03)12680-3","article-title":"Antenatal screening for Down\u2019s syndrome with the quadruple test","volume":"361","author":"Wald","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-2004-831899","article-title":"Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome","volume":"22","author":"Lambert-Messerlian","year":"2004","journal-title":"Semin Reprod Med"},{"issue":"6","key":"10.1016\/j.gim.2025.101505_bib3","article-title":"Second trimester serum tests for Down\u2019s syndrome screening","volume":"2012","author":"Alldred","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.GIM.0000167808.96439.F3","article-title":"Technical standards and guidelines: prenatal screening for Down syndrome","volume":"7","author":"Palomaki","year":"2005","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2025.101505_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1471-0528.2002.01394.x","article-title":"Combined ultrasound and biochemical screening for Down\u2019s syndrome in the first trimester: a Scottish multicentre study","volume":"109","author":"Crossley","year":"2002","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/uog.1860","article-title":"Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening","volume":"25","author":"Nicolaides","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.gim.2025.101505_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pd.1970151305","article-title":"First trimester serum screening for Down\u2019s syndrome","volume":"15","author":"Wald","year":"1995","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1016\/j.gim.2025.101505_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/GIM.0b013e3181ad5246","article-title":"Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and\/or ultrasound measurements","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199908123410701","article-title":"Integrated screening for Down\u2019s syndrome based on tests performed during the first and second trimesters","volume":"341","author":"Wald","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gim.2025.101505_bib10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/pd.1305","article-title":"Integrated serum screening for Down syndrome in primary obstetric practice","volume":"25","author":"Knight","year":"2005","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1016\/j.gim.2025.101505_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pd.1498","article-title":"Sequential and contingent prenatal screening for Down syndrome","volume":"26","author":"Wald","year":"2006","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.gim.2025.101505_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pd.974","article-title":"Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening","volume":"24","author":"Wright","year":"2004","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058732","article-title":"Incorporating DNA sequencing into current prenatal screening practice for Down\u2019s syndrome","volume":"8","author":"Wald","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gim.2025.101505_bib14","article-title":"Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down\u2019s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units","volume":"354","author":"Chitty","year":"2016","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.gim.2025.101505_bib15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/(SICI)1097-0223(199912)19:12<1180::AID-PD732>3.0.CO;2-V","article-title":"Fetal loss in Down syndrome pregnancies","volume":"19","author":"Snijders","year":"1999","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ajmg.a.32220","article-title":"The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18","volume":"146A","author":"Morris","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.gim.2025.101505_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L","article-title":"Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening","volume":"62","author":"Hecht","year":"1996","journal-title":"Am J Med Genet"},{"issue":"8383","key":"10.1016\/j.gim.2025.101505_bib18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(84)92389-4","article-title":"Maternal serum alpha fetoprotein measurement: a screening test for Down syndrome","volume":"1","author":"Cuckle","year":"1984","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jms.5.3.115","article-title":"Second trimester screening for Down\u2019s syndrome using maternal serum dimeric inhibin A","volume":"5","author":"Haddow","year":"1998","journal-title":"J Med Screen"},{"issue":"6653","key":"10.1016\/j.gim.2025.101505_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down\u2019s syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gim.2025.101505_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F","article-title":"Prenatal screening for Down\u2019s syndrome using inhibin-A as a serum marker","volume":"16","author":"Wald","year":"1996","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0223(199703)17:3<285::AID-PD71>3.0.CO;2-A","article-title":"Inhibin-A in Down\u2019s syndrome pregnancies: revised estimate of standard deviation","volume":"17","author":"Wald","year":"1997","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.gim.2025.101505_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/pd.1970140810","article-title":"Four-marker serum screening for Down\u2019s syndrome","volume":"14","author":"Wald","year":"1994","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.gim.2025.101505_bib24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/(SICI)1097-0223(199610)16:10<927::AID-PD972>3.0.CO;2-0","article-title":"Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down\u2019s syndrome","volume":"16","author":"Watt","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.gim.2025.101505_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0065-2423(06)43006-7","article-title":"A summary analysis of Down syndrome markers in the late first trimester","volume":"43","author":"Palomaki","year":"2007","journal-title":"Adv Clin Chem"},{"issue":"19","key":"10.1016\/j.gim.2025.101505_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","article-title":"Dimeric inhibin A as a marker for Down\u2019s syndrome in early pregnancy","volume":"334","author":"Aitken","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.gim.2025.101505_bib27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/(SICI)1097-0223(199809)18:9<926::AID-PD377>3.0.CO;2-F","article-title":"Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening","volume":"18","author":"Cole","year":"1998","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.gim.2025.101505_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.351","article-title":"Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-\u03b2 human chorionic gonadotrophin, placental growth factor, and \u03b1-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.gim.2025.101505_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9378(89)90237-8","article-title":"First-trimester and early second-trimester diagnosis of nuchal cystic hygroma by transvaginal sonography: diverse prognosis of the septated from the nonseptated lesion","volume":"161","author":"Bronshtein","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"8723","key":"10.1016\/j.gim.2025.101505_bib31","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0140-6736(90)92614-N","article-title":"Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester","volume":"336","author":"Szab\u00f3","year":"1990","journal-title":"Lancet"},{"issue":"6831","key":"10.1016\/j.gim.2025.101505_bib32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.304.6831.867","article-title":"Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy","volume":"304","author":"Nicolaides","year":"1992","journal-title":"BMJ"},{"issue":"9125","key":"10.1016\/j.gim.2025.101505_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(97)11280-6","article-title":"UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group","volume":"352","author":"Snijders","year":"1998","journal-title":"Lancet"},{"issue":"5 Pt 1","key":"10.1016\/j.gim.2025.101505_bib34","first-page":"1066","article-title":"First-trimester sonographic screening for Down syndrome","volume":"102","author":"Malone","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"9076","key":"10.1016\/j.gim.2025.101505_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"issue":"51","key":"10.1016\/j.gim.2025.101505_bib36","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.gim.2025.101505_bib37","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.gim.2025.101505_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000358326","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis","volume":"35","author":"Gil","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.gim.2025.101505_bib42","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/gim.2018.22","article-title":"Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing","volume":"20","author":"Palomaki","year":"2018","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/gim.2013.29","article-title":"ACMG statement on noninvasive prenatal screening for fetal aneuploidy","volume":"15","author":"Gregg","year":"2013","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.gim.2025.101505_bib44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2025.101505_bib45","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/pd.6574","article-title":"Numbers of prenatal cell-free DNA screens performed: results of a 2022 CAP exercise","volume":"44","author":"Palomaki","year":"2024","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41436-019-0681-0","article-title":"Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Palomaki","year":"2020","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2025.101505_bib48","first-page":"207","article-title":"First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency","volume":"96","author":"Krantz","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gim.2025.101505_bib49","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinchem\/39.6.1064","article-title":"Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole-blood filter-paper spots: impact on screening for Down syndrome by measurement of free beta-hCG subunit","volume":"39","author":"Spencer","year":"1993","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.gim.2025.101505_bib50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0002-9378(96)70429-5","article-title":"Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome","volume":"174","author":"Macri","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"1 Pt 1","key":"10.1016\/j.gim.2025.101505_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0002-9378(95)90108-6","article-title":"A prenatal trisomy 21 screening program using alpha-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood","volume":"172","author":"Verloes","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gim.2025.101505_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pd.1326","article-title":"Stability of first- and second-trimester serum markers after storage and shipment","volume":"26","author":"Lambert-Messerlian","year":"2006","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.gim.2025.101505_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.2004.00193.x","article-title":"SURUSS in perspective","volume":"111","author":"Wald","year":"2004","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib54","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.AOG.0000241095.19638.f2","article-title":"Comparison of serum markers in first-trimester down syndrome screening","volume":"108","author":"Canick","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gim.2025.101505_bib55","first-page":"56","article-title":"First and second trimester antenatal screening for Down\u2019s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen"},{"issue":"19","key":"10.1016\/j.gim.2025.101505_bib56","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down\u2019s syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajog.2006.08.001","article-title":"Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol","volume":"196","author":"Evans","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gim.2025.101505_bib58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.semperi.2005.05.004","article-title":"Down syndrome screening in the first and\/or second trimester: model predicted performance using meta-analysis parameters","volume":"29","author":"Cuckle","year":"2005","journal-title":"Semin Perinatol"},{"issue":"4","key":"10.1016\/j.gim.2025.101505_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","article-title":"Antenatal screening for Down\u2019s syndrome","volume":"4","author":"Wald","year":"1997","journal-title":"J Med Screen"},{"key":"10.1016\/j.gim.2025.101505_bib61","series-title":"Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics","article-title":"Quality management","author":"Klee","year":"2015"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.5858\/arpa.2012-0319-CP","article-title":"Screening for down syndrome in the United States: results of surveys in 2011 and 2012","volume":"137","author":"Palomaki","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib63","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0002-9378(97)70400-9","article-title":"Maternal serum screening for Down syndrome in the United States: a 1995 survey","volume":"176","author":"Palomaki","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gim.2025.101505_bib64","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pd.5832","article-title":"International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies","volume":"41","author":"Palomaki","year":"2021","journal-title":"Prenat Diagn"},{"issue":"14","key":"10.1016\/j.gim.2025.101505_bib65","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM199804023381404","article-title":"Screening of maternal serum for fetal Down\u2019s syndrome in the first trimester","volume":"338","author":"Haddow","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gim.2025.101505_bib66","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6","article-title":"Refinements in managing maternal weight adjustment for interpreting prenatal screening results","volume":"16","author":"Neveux","year":"1996","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib67","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/AOG.0000000000005045","article-title":"Reconsidering race adjustment in prenatal alpha-fetoprotein screening","volume":"141","author":"Burns","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib68","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/clinchem\/hvae053","article-title":"Use of maternal race and weight provides equitable performance in serum screening for open neural tube defects","volume":"70","author":"Messerlian","year":"2024","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.gim.2025.101505_bib69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-0528.1979.tb10575.x","article-title":"Maternal serum alpha fetoprotein and diabetes mellitus","volume":"86","author":"Wald","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"10.1016\/j.gim.2025.101505_bib70","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#","article-title":"Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme","volume":"16","author":"Crossley","year":"1996","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/pd.72","article-title":"Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?","volume":"21","author":"Sancken","year":"2001","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.gim.2025.101505_bib72","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1067\/mob.2002.126651","article-title":"Correction for insulin-dependent diabetes in maternal serum alpha fetoprotein testing has outlived its usefulness","volume":"187","author":"Evans","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gim.2025.101505_bib73","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pd.994","article-title":"Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus","volume":"24","author":"Huttly","year":"2004","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.gim.2025.101505_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pd.2755","article-title":"Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters","volume":"31","author":"Zhang","year":"2011","journal-title":"Prenat Diagn"},{"issue":"12","key":"10.1016\/j.gim.2025.101505_bib75","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-0528.1999.tb08186.x","article-title":"Serum markers for Down\u2019s syndrome in women who have had in vitro fertilisation: implications for antenatal screening","volume":"106","author":"Wald","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.gim.2025.101505_bib76","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/pd.1469","article-title":"First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study","volume":"26","author":"Lambert-Messerlian","year":"2006","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib77","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1067\/mob.2002.126986","article-title":"Biochemical screening for aneuploidy in ovum donor pregnancies","volume":"187","author":"Donnenfeld","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gim.2025.101505_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jms.9.1.2","article-title":"Revised estimates of the maternal age specific live birth prevalence of Down\u2019s syndrome","volume":"9","author":"Morris","year":"2002","journal-title":"J Med Screen"},{"issue":"1","key":"10.1016\/j.gim.2025.101505_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pd.2403","article-title":"The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome)","volume":"30","author":"Savva","year":"2010","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2025.101505_bib80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-0223(199803)18:3<235::AID-PD248>3.0.CO;2-A","article-title":"hCG and the free beta-subunit as screening tests for Down syndrome","volume":"18","author":"Knight","year":"1998","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.gim.2025.101505_bib81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","article-title":"Estimating a woman\u2019s risk of having a pregnancy associated with Down\u2019s syndrome using her age and serum alpha-fetoprotein level","volume":"94","author":"Cuckle","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/pd.1970140716","article-title":"Repeat maternal serum testing in multiple marker Down\u2019s syndrome screening programmes","volume":"14","author":"Cuckle","year":"1994","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.gim.2025.101505_bib83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1097-0223(200101)21:1<58::AID-PD964>3.0.CO;2-9","article-title":"Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers","volume":"21","author":"Hackshaw","year":"2001","journal-title":"Prenat Diagn"},{"issue":"8476","key":"10.1016\/j.gim.2025.101505_bib84","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gim.2025.101505_bib85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0272-2712(03)00023-4","article-title":"Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome","volume":"23","author":"Knight","year":"2003","journal-title":"Clin Lab Med"},{"issue":"2 Pt 1","key":"10.1016\/j.gim.2025.101505_bib86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.AOG.0000195061.48747.f4","article-title":"Comparing three screening strategies for combining first- and second-trimester Down syndrome markers","volume":"107","author":"Palomaki","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gim.2025.101505_bib87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2393-14-229","article-title":"Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol","volume":"14","author":"Hill","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.gim.2025.101505_bib88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0969141315617982","article-title":"Antenatal reflex DNA screening for trisomy 18 and trisomy 13 in addition to Down\u2019s syndrome","volume":"23","author":"Bestwick","year":"2016","journal-title":"J Med Screen"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220053","article-title":"Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13","volume":"14","author":"Bestwick","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.gim.2025.101505_bib90","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/gim.2017.188","article-title":"Prenatal reflex DNA screening for trisomies 21, 18, and 13","volume":"20","author":"Wald","year":"2018","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101505_bib91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pd.4784","article-title":"Prenatal reflex DNA screening for Down syndrome: enhancing the screening performance of the initial first trimester test","volume":"36","author":"Wald","year":"2016","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.gim.2025.101505_bib92","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.gim.2022.03.019","article-title":"Systematic evidence-based review: the application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies","volume":"24","author":"Rose","year":"2022","journal-title":"Genet Med"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:03:05Z","timestamp":1788235385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1098360025001522"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101505","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101505"}}